Zepto is bolstering its domestic shareholding by involving notable Indian family offices, including those of Manipal group chief Ranjan Pai and Mankind Pharma brothers. Recently valued at $5 billion, Zepto is also moving its parent company to India, aiming to boost government confidence and align with FDI regulations for a favorable market stance.